Jill Beraud

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Priscilla Duncan-Tannous, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jill Beraud:

Company Role Class Num Shares Value Price $ Report Date Ownership
LEVI STRAUSS & CO Director Class A Common Stock 172,776 $3,548,819 $20.54 25 Feb 2026 Direct
LEVI STRAUSS & CO Director Class B Common Stock 14,285 $2,197,734 $17.93 25 Feb 2026 Direct
Revance Therapeutics, Inc. Director Common Stock 0 $0 $3.65 06 Feb 2025 Direct
Revance Therapeutics, Inc. Director Stock Option (Right to buy) 23,458 01 May 2024 Direct

Insider Reports Filed by Jill Beraud

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LEVI LEVI STRAUSS & CO 25 Feb 2026 2 $0 4 Director 27 Feb 2026, 17:06
LEVI LEVI STRAUSS & CO 04 Nov 2025 2 $0 4 Director 06 Nov 2025, 16:14
LEVI LEVI STRAUSS & CO 08 Aug 2025 2 $0 4 Director 12 Aug 2025, 16:53
LEVI LEVI STRAUSS & CO 09 May 2025 2 $0 4 Director 12 May 2025, 21:57
LEVI LEVI STRAUSS & CO 23 Apr 2025 3 $0 4 Director 25 Apr 2025, 16:19
LEVI LEVI STRAUSS & CO 28 Feb 2025 2 $0 4 Director 04 Mar 2025, 16:47
/report/000095017025015341-beraud-jill-2025-02-04 Revance Therapeutics, Inc. 04 Feb 2025 2 -$104,412 4 Director 06 Feb 2025, 15:49
LEVI LEVI STRAUSS & CO 14 Nov 2024 2 $0 4 Director 18 Nov 2024, 16:52
LEVI LEVI STRAUSS & CO 20 Aug 2024 2 $0 4 Director 22 Aug 2024, 20:46
LEVI LEVI STRAUSS & CO 23 May 2024 2 $0 4 Director 28 May 2024, 17:33
/report/000147929024000084-beraud-jill-2024-05-01 Revance Therapeutics, Inc. 01 May 2024 2 $0 4 Director 03 May 2024, 08:42
LEVI LEVI STRAUSS & CO 24 Apr 2024 1 $0 4 Director 26 Apr 2024, 20:59
LEVI LEVI STRAUSS & CO 23 Feb 2024 2 $0 4 Director 27 Feb 2024, 18:24
LEVI LEVI STRAUSS & CO 09 Nov 2023 2 $0 4 Director 13 Nov 2023, 20:44
LEVI LEVI STRAUSS & CO 17 Aug 2023 2 $0 4 Director 21 Aug 2023, 18:33
LEVI LEVI STRAUSS & CO 18 May 2023 2 $0 4 Director 22 May 2023, 20:58
/report/000147929023000058-beraud-jill-2023-05-03 Revance Therapeutics, Inc. 03 May 2023 2 $0 4 Director 05 May 2023, 17:13
LEVI LEVI STRAUSS & CO 19 Apr 2023 1 $0 4 Director 21 Apr 2023, 18:39
LEVI LEVI STRAUSS & CO 23 Feb 2023 2 $0 4 Director 27 Feb 2023, 20:56
LEVI LEVI STRAUSS & CO 21 Nov 2022 1 $0 4 Director 23 Nov 2022, 15:06
LEVI LEVI STRAUSS & CO 17 Aug 2022 1 $0 4 Director 18 Aug 2022, 16:23
LEVI LEVI STRAUSS & CO 24 May 2022 1 $0 4 Director 25 May 2022, 18:34
/report/000147929022000065-beraud-jill-2022-05-04-restatement Revance Therapeutics, Inc. 04 May 2022 1 $0 4/A Director 13 May 2022, 18:08
LEVI LEVI STRAUSS & CO 20 Apr 2022 1 $0 4 Director 22 Apr 2022, 16:05
LEVI LEVI STRAUSS & CO 24 Feb 2022 1 $0 4 Director 28 Feb 2022, 15:34
LEVI LEVI STRAUSS & CO 17 Nov 2021 1 $0 4 Director 18 Nov 2021, 16:03
LEVI LEVI STRAUSS & CO 18 Aug 2021 1 $0 4 Director 02 Sep 2021, 17:16
LEVI LEVI STRAUSS & CO 15 Jul 2021 1 $0 4 Director 19 Jul 2021, 21:16
LEVI LEVI STRAUSS & CO 25 May 2021 1 $0 4 Director 26 May 2021, 20:20
/report/000147929021000106-beraud-jill-2021-05-05 Revance Therapeutics, Inc. 05 May 2021 2 $0 4 Director 07 May 2021, 19:04
LEVI LEVI STRAUSS & CO 25 Mar 2019 4 $0 4/A Director 21 Apr 2023, 18:20